Header image

Transforming global genetic data into medical decisions

Our goal is the rapid medical diagnosis of inherited diseases, provided at the earliest possible moment as we turn analytical information into actionable results for physicians, patients and pharmaceutical partners.

Our commitment to the global medical community is an early and precise diagnosis for continuous improvement of therapeutic options for each individual patient.

Latest Scientific News

De novo ITPR1 variants are a cause of early-onset ataxia

We explored the clinico-genetic basis of spinocerebellar ataxia 29 (SCA29) by determining…

Evolution of outcome measures in spinocerebellar ataxias

To study the long-term evolution of patient-reported outcome measures (PROMs) in the most…

The first missense pathogenic variant in the KAT6A gene

CENTOGENE published results of another successful collaborative study in the highly ranked…

Comprehensive Carrier Screening

Carrier screening is a genetic test used to determine if a healthy person is a carrier of…

Customer Feedback

Give feedback

Newsletter subscription

We are proud to have been honored with the award from the Federal State Government of Mecklenburg-Vorpommern in the category ‘Company Development’. We are...

Read more

ROSTOCK, GERMANY, June 7, 2018 – CENTOGENE announced today a partnering with the Medical Faculties of the Universities of Greifswald and Rostock for the...

Read more

Rostock, Germany, June 5, 2018 –CENTOGENE announced today the opening of its first U.S. based rare disease laboratory in Cambridge, Massachusetts.  The new...

Read more

CENTOGENE, driving the diagnostic workflows and individualized therapeutic decisions not only in rare diseases but also in oncological setups is proud to host...

Read more

ROSTOCK, GERMANY, June 1, 2018 – CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical...

Read more

Collaboration Builds on Genetic Identification of Patients with Sjögren-Larsson Syndrome (SLS) in a Worldwide Cohort Enabling SLS Patients to Benefit from Novel...

Read more

This year´s European Conference on Rare Diseases and Orphan Products (ECRD 2018 Vienna) gathered over 800 participants from patient organizations, academics,...

Read more

CENTOGENE’s Deep Expertise in Biomarker Identification to Help Guide Clinical Trials

Read more

ROSTOCK, GERMANY, May 9, 2018 – CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and...

Read more